Treatment of Dyslipidemia through Targeted Therapy of Gut Microbiota
Dyslipidemia is a multifaceted condition with various genetic and environmental factors contributing to its pathogenesis. Further, this condition represents an important risk factor for its related sequalae including cardiovascular diseases (CVD) such as coronary artery disease (CAD) and stroke. Eme...
Main Authors: | Brandon Flaig, Rachel Garza, Bhavdeep Singh, Sevag Hamamah, Mihai Covasa |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/15/1/228 |
Similar Items
-
Dietary Fat Modulation of Gut Microbiota and Impact on Regulatory Pathways Controlling Food Intake
by: Sevag Hamamah, et al.
Published: (2023-07-01) -
Gut microbiome-targeted therapies in liver cirrhosis: a protocol for systematic review and meta-analysis
by: Honglin Jiang, et al.
Published: (2022-08-01) -
Gut microbiome-targeted therapies for Alzheimer’s disease
by: Tao Zhang, et al.
Published: (2023-12-01) -
Therapeutic methods of gut microbiota modification in colorectal cancer management – fecal microbiota transplantation, prebiotics, probiotics, and synbiotics
by: Karolina Kaźmierczak-Siedlecka, et al.
Published: (2020-11-01) -
Gut Microbiome Modulation and Faecal Microbiota Transplantation Following Allogenic Hematopoietic Stem Cell Transplantation
by: Karolina Kaźmierczak-Siedlecka, et al.
Published: (2021-09-01)